REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4 | -100.0% | 25,000 | -42.6% | 0.00% | -93.3% |
| Q2 2022 | $38,000 | -65.5% | 43,532 | 0.0% | 0.02% | -65.1% |
| Q1 2022 | $110,000 | -1.8% | 43,532 | 0.0% | 0.04% | -12.2% |
| Q4 2021 | $112,000 | -43.7% | 43,532 | 0.0% | 0.05% | -59.2% |
| Q3 2021 | $199,000 | -33.7% | 43,532 | 0.0% | 0.12% | -33.7% |
| Q2 2021 | $300,000 | -6.0% | 43,532 | 0.0% | 0.18% | -19.9% |
| Q1 2021 | $319,000 | -9.4% | 43,532 | 0.0% | 0.23% | -23.1% |
| Q4 2020 | $352,000 | – | 43,532 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |